CMRX
CorMedix Announces Q3 2026 Earnings
CorMedix reported Q3 2026 earnings; the company announced a proposed acquisition of Heron Therapeutics assets. Market relevance: indicates a period of corporate transition and M&A activity.
Latest 1 stories · newest Nov 14, 2026
CorMedix reported Q3 2026 earnings; the company announced a proposed acquisition of Heron Therapeutics assets. Market relevance: indicates a period of corporate transition and M&A activity.
The same CMRX feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/CMRX/newsSTART FREE